BRAIN Biotech AG (BNN) — Cash Flow Quality Index

Latest as of March 2021: -0.98x

BRAIN Biotech AG (BNN) has a Cash Flow Quality Index of -0.98x as of March 2021. Operating cash flow of €-2.02 Million is below net income of €2.07 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BNN long-term investments to assets to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.98x

Operating CF / Net Income

Operating Cash Flow

€-2.02 Million

EUR

Net Income

€2.07 Million

EUR

Data as of

Mar 2021

Most recent filing

Annual Cash Flow Quality Index for BRAIN Biotech AG (None–None)

Year-by-year earnings quality comparison for BRAIN Biotech AG. For live market cap and the full company financial profile, see BRAIN Biotech AG market capitalisation.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.